Jian Gao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jian Gao has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
- Zhiwei Cao
School of Life Sciences and Technology, Tongji University
66 shared publications - Haiquan Chen
Department of Thoracic Surgery and State Key Laboratory of Genetics and Development of Complex Phenotypes, Fudan University Shanghai Cancer Center, Shanghai, China
64 shared publications - Yue Zhao
Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China
64 shared publications - Jun Wang
School of Life Sciences, Fudan University, Shanghai, China
63 shared publications - Fanfan Fan
Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China
62 shared publications - Xiaoming Zhang
National Key Laboratory of Immune Response and Immunotherapy, Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai, China
62 shared publications
Latest Publications
- Open Access
- 18 May 2026
- Published by Springer Nature in Phenomics
- Vol. 6 (3) , 247-256
HuNT: A Reference Transcriptome Atlas for Human Normal Tissues
With the rapid development of transcriptomics technology, gene expression profiles of normal human tissues have been frequently utilized as valuable references to study aging and disease mechanisms. Although individual databases have been established, most human tissues remain under-sampled. Meanwhile, profiles from RNA-seq and microarray platforms must be analyzed separately due to inherent distribution bias, further weakening the statistical power of health samples. Here, we constructed a comprehensive transcriptome atlas for human normal tissues (HuNT) containing 29,769 samples covering 74 human normal tissue types or parts, 70% and 37% larger than those in the well-known GTEx database in terms of sample size and tissue diversity, respectively. More importantly, instead of separate calculation, integrative analysis has been enabled for hybrid samples across RNA-seq and microarray profiles per tissue type. Based on the largest human sample collection so far, HuNT provides the latest information on: (1) tissue-specific genes, (2) stably and highly expressed housekeeping genes for each tissue, (3) gene expression landscape across all human tissues, and (4) top correlated genes for a query in a specified tissue. A case study of four widely-acknowledged biomarkers is also illustrated in the paper. With future data accumulation, HuNT may be useful to provide not only gene expression landscapes in human normal tissues, but also benchmarks to derive interesting marker genes and even therapeutic targets. HuNT is now freely accessible at http://hunt.badd-cao.net/ .
- 18 May 2026
- Published by Springer Nature in Phenomics
- Vol. 6 (3) , 247-256
Open AccessHuNT: A Reference Transcriptome Atlas for Human Normal Tissues
With the rapid development of transcriptomics technology, gene expression profiles of normal human tissues have been frequently utilized as valuable references to study aging and disease mechanisms. Although individual databases have been established, most human tissues remain under-sampled. Meanwhile, profiles from RNA-seq and microarray platforms must be analyzed separately due to inherent distribution bias, further weakening the statistical power of health samples. Here, we constructed a comprehensive transcriptome atlas for human normal tissues (HuNT) containing 29,769 samples covering 74 human normal tissue types or parts, 70% and 37% larger than those in the well-known GTEx database in terms of sample size and tissue diversity, respectively. More importantly, instead of separate calculation, integrative analysis has been enabled for hybrid samples across RNA-seq and microarray profiles per tissue type. Based on the largest human sample collection so far, HuNT provides the latest information on: (1) tissue-specific genes, (2) stably and highly expressed housekeeping genes for each tissue, (3) gene expression landscape across all human tissues, and (4) top correlated genes for a query in a specified tissue. A case study of four widely-acknowledged biomarkers is also illustrated in the paper. With future data accumulation, HuNT may be useful to provide not only gene expression landscapes in human normal tissues, but also benchmarks to derive interesting marker genes and even therapeutic targets. HuNT is now freely accessible at http://hunt.badd-cao.net/ .
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Data from Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2+ Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma
Mast cells constitute indispensable immunoregulatory sentinel cells in the tumor microenvironment. A better understanding of the regulation and functions of mast cells in lung adenocarcinoma (LUAD) could uncover therapeutic approaches to reprogram the immunosuppressive tumor microenvironment. Here, we performed flow cytometry and single-cell RNA sequencing (scRNA-seq) of patient LUAD samples to comprehensively characterize LUAD-infiltrating mast cells. Mast cells exhibited functional heterogeneity and were enriched in LUAD with ground-glass opacity features (gLUAD). The mast cells in gLUAD exhibited proinflammatory and chemotactic properties while those in radiologically solid LUAD (sLUAD) were associated with tumor angiogenesis. Mast cells were an important source of CCL2 and correlated with the recruitment of CCR2+ CTL, a specific subcluster of preexhausted T cells with tissue-resident memory phenotype and enhanced cytotoxicity. Increased infiltration of mast cells and CCR2+ CTLs and their colocalization showed a strong association with favorable prognosis after surgery but were not associated with improved survival after chemotherapy. Collectively, these findings reveal a key role of mast cells in LUAD and their potential cross-talk with CTLs, suggesting that targeting mast cells may be an immunotherapeutic strategy for LUAD.Significance:Comprehensive characterization of mast cells in lung adenocarcinoma elucidates their heterogeneity and identifies interplay between mast cells and CCR2+ T cells that is associated with a favorable prognosis.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2+ Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma
Mast cells constitute indispensable immunoregulatory sentinel cells in the tumor microenvironment. A better understanding of the regulation and functions of mast cells in lung adenocarcinoma (LUAD) could uncover therapeutic approaches to reprogram the immunosuppressive tumor microenvironment. Here, we performed flow cytometry and single-cell RNA sequencing (scRNA-seq) of patient LUAD samples to comprehensively characterize LUAD-infiltrating mast cells. Mast cells exhibited functional heterogeneity and were enriched in LUAD with ground-glass opacity features (gLUAD). The mast cells in gLUAD exhibited proinflammatory and chemotactic properties while those in radiologically solid LUAD (sLUAD) were associated with tumor angiogenesis. Mast cells were an important source of CCL2 and correlated with the recruitment of CCR2+ CTL, a specific subcluster of preexhausted T cells with tissue-resident memory phenotype and enhanced cytotoxicity. Increased infiltration of mast cells and CCR2+ CTLs and their colocalization showed a strong association with favorable prognosis after surgery but were not associated with improved survival after chemotherapy. Collectively, these findings reveal a key role of mast cells in LUAD and their potential cross-talk with CTLs, suggesting that targeting mast cells may be an immunotherapeutic strategy for LUAD.Significance:Comprehensive characterization of mast cells in lung adenocarcinoma elucidates their heterogeneity and identifies interplay between mast cells and CCR2+ T cells that is associated with a favorable prognosis.